Teva Pharmaceutical Industries Ltd

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

5,654

Value ($000)

176

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	176	0.0%	5,654	12/31/2025
2025 Q3	11/14/2025	1,115	0.0%	55,198	9/30/2025
2025 Q2	8/14/2025	78,298	0.0%	4,671,735	6/30/2025
2025 Q1	5/19/2025	54,369	0.0%	3,537,324	3/31/2025
2024 Q4	2/14/2025	73,637	0.0%	3,341,063	12/31/2024
2024 Q3	11/14/2024	60,863	0.0%	3,377,517	9/30/2024
2024 Q2	8/14/2024	16,264	0.0%	1,000,849	6/30/2024
2024 Q1	5/15/2024	31,373	0.0%	2,223,464	3/31/2024
2023 Q4	2/14/2024	23,625	0.0%	2,262,950	12/31/2023
2023 Q3	11/13/2023	23,362	0.0%	2,290,351	9/30/2023
2023 Q2	8/11/2023	16,979	0.0%	1,918,483	6/30/2023
2023 Q1	5/15/2023	16,979	0.0%	1,918,483	3/31/2023
2022 Q4	2/14/2023	16,693	0.0%	1,830,406	12/31/2022
2022 Q3	11/14/2022	13,535	0.0%	1,677,225	9/30/2022
2022 Q2	8/12/2022	13,579	0.0%	1,805,740	6/30/2022
2022 Q1	5/16/2022	16,900	0.0%	1,799,760	3/31/2022
2021 Q4	2/14/2022	15,143	0.0%	1,890,475	12/31/2021
2021 Q3	11/15/2021	18,641	0.0%	1,913,840	9/30/2021
2021 Q2	8/16/2021	17,651	0.0%	1,782,968	6/30/2021
2021 Q1	5/14/2021	21,601	0.0%	1,871,825	3/31/2021
2020 Q4	3/1/2021	18,650	0.0%	1,932,680	12/31/2020
2020 Q3	11/13/2020	17,572	0.0%	1,950,290	9/30/2020
2020 Q2	8/14/2020	23,863	0.0%	1,935,377	6/30/2020
2020 Q1	5/15/2020	17,900	0.0%	1,993,357	3/31/2020
2019 Q4	2/14/2020	18,637	0.0%	1,901,712	12/31/2019
2014 Q1	5/23/2014	45,105	0.0%	853,619	3/31/2014
2013 Q4	1/31/2014	44,299	0.1%	1,105,255	12/31/2013